Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis

V Elangovan1, N Sekar, S Govindasamy

  • 1Department of Biochemistry, University of Madras, India.

Cancer Letters
|November 25, 1994
PubMed

Insights

Dietary flavonoids like quercetin and luteolin significantly reduced fibrosarcoma incidence in mice. These compounds inhibited DNA synthesis and enhanced detoxification, offering potential cancer prevention strategies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Flavonoids are plant-derived polyphenolic compounds with known antioxidant and anti-inflammatory properties.
  • Dietary supplementation is explored for cancer chemoprevention, but specific mechanisms require elucidation.

Purpose of the Study:

  • To investigate the chemopreventive effects of dietary flavonoids (quercetin, rutin, luteolin, (+)-catechin) against 20-methylcholanthrene (20-MC)-induced fibrosarcoma in mice.
  • To explore the impact of these flavonoids on tumor incidence, expression, and key biochemical markers associated with carcinogenesis.

Main Methods:

  • Male Swiss albino mice were administered 20-methylcholanthrene (20-MC) to induce fibrosarcoma.
  • Mice received dietary supplementation with quercetin, rutin, luteolin, or (+)-catechin.
  • Tumor incidence, onset, and expression were monitored.
  • Levels of lipid peroxides, cytochrome P450, and glutathione-S-transferase (GST) activity were assessed in tumor-bearing and treated animals.
  • In vitro DNA synthesis inhibition was measured using [3H]thymidine incorporation.

Main Results:

  • 20-MC induced 100% fibrosarcoma incidence within 7 weeks.
  • Dietary quercetin (52% incidence) and luteolin (60% incidence) significantly reduced tumor incidence and delayed onset (9th week).
  • Rutin and (+)-catechin did not affect tumor expression.
  • Flavonoid treatment reduced lipid peroxides and cytochrome P450, while increasing GST activity (P < 0.001).
  • In vitro studies demonstrated flavonoid inhibition of DNA synthesis in fibrosarcoma cells.

Conclusions:

  • Quercetin and luteolin exhibit significant chemopreventive effects against 20-MC-induced fibrosarcoma.
  • These flavonoids may act by inhibiting tumor initiation/promotion and enhancing detoxification pathways.
  • Flavonoids show potential as dietary agents for cancer prevention through modulation of key carcinogenic processes.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...